Vanguard U.S. Multifactor ETF
VFMF - ETF AI Analysis
Top Page
Vanguard U.S. Multifactor ETF (VFMF)
VFMF, the Vanguard U.S. Multifactor ETF, has a solid overall rating, largely supported by strong, diversified holdings like Newmont Mining, Travelers, Amgen, Gilead, and ConocoPhillips, which all show healthy financial performance, positive earnings commentary, and generally supportive technical and valuation profiles. Some holdings such as Valero Energy and Altria introduce risks through valuation concerns, technical weakness, and industry-specific challenges, and the fund’s exposure to energy and financials means performance can be sensitive to shifts in those sectors.
VFMF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.16B
- Region
- North America
- Expense Ratio
- 0.18%
- Beta
- 0.83
- Issuer
- Vanguard
- Inception Date
- Feb 13, 2018
- Dividend Yield
- 1.39%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
VFMF Summary
Vanguard U.S. Multifactor ETF (VFMF) is a fund that invests across the U.S. stock market, using a rules-based “multifactor” strategy instead of tracking a single index. It focuses on companies that score well on value, momentum, and quality, and spreads money across many sectors like financials, technology, health care, and energy. Well-known holdings include Amgen and Allstate. Someone might invest in VFMF for broad diversification and the potential for long-term growth from its factor-based approach. A key risk is that it still moves up and down with the overall stock market and can underperform simple index funds at times.
How much will it cost me?
This ETF has an expense ratio of 0.18%, which means you’ll pay about $1.80 per year for every $1,000 you invest. That’s slightly higher than the cheapest plain index ETFs because this fund is actively managed using a multifactor strategy (value, momentum, and quality) rather than simply tracking a basic market index.
What would affect this ETF?
This ETF focuses on U.S. stocks with a tilt toward financials, energy, health care, and technology, so it could benefit if the U.S. economy stays strong, corporate profits grow, and sectors like energy and tech perform well, helping holdings such as Valero, Marathon Petroleum, Micron, and Amgen. On the downside, higher interest rates, weaker U.S. growth, tighter financial regulations, or sector-specific issues in banks, energy, or health care could hurt these companies and weigh on the fund’s overall returns.
VFMF Top 10 Holdings
VFMF’s story right now is being written largely by its energy and tech names. Refiners like Marathon Petroleum and Valero, along with producers such as ConocoPhillips and EOG Resources, have been rising and giving the fund a solid tailwind, helped by steady performance from Newmont in materials. On the tech side, Micron and Dell have delivered strong year-to-date gains, even if their recent momentum has been a bit mixed, adding a growth spark to the portfolio. With all holdings U.S.-based and a tilt toward energy, technology, and financials, this multifactor ETF is diversified but not shy about backing cyclical winners.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NEM | Newmont Mining | 0.90% | $10.48M | $124.66B | 35.92% | 81Outperform |
 TGT | Target | 0.90% | $10.44M | $73.50B | 78.31% | 70Neutral |
 TRV | Travelers Companies | 0.89% | $10.38M | $82.14B | 41.92% | 78Outperform |
 ALL | Allstate | 0.88% | $10.25M | $64.61B | 28.07% | 74Outperform |
 VLO | Valero Energy | 0.86% | $10.01M | $97.81B | 95.73% | 69Neutral |
 AMGN | Amgen | 0.84% | $9.77M | $251.65B | 43.74% | 77Outperform |
 MO | Altria Group | 0.84% | $9.73M | $126.99B | 32.65% | 64Neutral |
 WDC | Western Digital | 0.81% | $9.38M | $108.25B | 66.00% | 77Outperform |
 GILD | Gilead Sciences | 0.80% | $9.36M | $211.94B | 44.62% | 78Outperform |
 COP | Conocophillips | 0.80% | $9.35M | $160.31B | 53.68% | 78Outperform |
VFMF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFMF, the sentiment is Positive. The current price of 185.79 is below the 20-day moving average (MA) of 186.26, above the 50-day MA of 184.18, and above the 200-day MA of 172.65, indicating a neutral trend. The MACD of 0.33 indicates Positive momentum. The RSI at 51.23 is Neutral, neither overbought nor oversold. The STOCH value of 39.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VFMF.
VFMF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VFMF | $185.79 | $200.00(7.65% Upside) | $1.16B | 0.18% | 70Outperform |
 QLTY | $44.26 | $52.79(19.27% Upside) | $7.37B | 0.50% | 75Outperform |
 AKRE | $60.27 | $71.43(18.51% Upside) | $4.96B | 0.98% | 68Neutral |
 TSPA | $47.24 | $57.95(22.68% Upside) | $4.66B | 0.34% | 74Outperform |
 DCOR | $83.21 | $100.93(21.30% Upside) | $3.66B | 0.14% | 72Outperform |
 FTHI | $23.02 | $27.70(20.31% Upside) | $2.55B | 0.75% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VFMF | Vanguard U.S. Multifactor ETF | 185.79 | 42.88 | 30.01% | |
| QLTY | GMO U.S. Quality ETF | 44.26 | 7.31 | 19.77% | |
| AKRE | Akre Focus ETF | 60.27 | -3.72 | -5.81% | |
| TSPA | T. Rowe Price U.S. Equity Research ETF | 47.24 | 5.17 | 12.29% | |
| DCOR | Dimensional US Core Equity 1 ETF | 83.21 | 11.74 | 16.42% | |
| FTHI | First Trust BuyWrite Income ETF | 23.02 | 1.47 | 6.82% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.